Summary
Dysregulation of matrix degrading metalloproteinase enzymes (MMPs) leads to increased extracellular matrix turnover, a key event in the local invasion and metastasis of many tumours. The tissue inhibitors of metalloproteinases (TIMPs) limit the activity of MMPs, which suggests their use in gene therapy. We have previously shown that overexpression of TIMP-1, -2 or -3 inhibits vascular smooth muscle and melanoma cell invasion, while TIMP-3 uniquely promotes apoptosis. We have therefore sought to determine whether TIMP-3 can inhibit invasion and promote apoptosis in other cancer cell types. Adenoviral-mediated overexpression of TIMP-3 inhibited invasion of HeLa and HT1080 cells through artificial basement membrane to similar levels as that achieved by TIMP-1 and -2. However, TIMP-3 uniquely promoted cell cycle entry and subsequent death by apoptosis. Apoptosis was confirmed by morphological analysis, terminal dUTP nick end labelling (TUNEL) and flow cytometry. The apoptotic phenotype was mimicked by addition of exogenous recombinant TIMP-3 to uninfected cultures demonstrating that the death signal is initiated extracellularly and that a bystander effect exists. These results show that TIMP-3 inhibits invasion in vitro and promotes apoptosis in cancer cell type of differing origin. This clearly identifies the potential of TIMP-3 for gene therapy of multiple cancer types.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahonen, M., Baker, A. H. & Kahari, V-M (1998). Adenovirus-mediated delivery of tissue inhibitor of metalloproteinase-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58: 2310–2315.
Apte, S. S., Hayashi, K., Seldin, M. F., Mattei, M. G., Hayashi, M. & Olsen, B. R. (1994). Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage and muscle, and is located on mouse chromosome-10. Dev Dyn 200: 177–197.
Baker, A. H., Wilkinson, G. W. G., Hembry, R. M., Murphy, G. & Newby, A. C. (1996). Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells. Matrix Biol 15: 383–395.
Baker, A. H., Zaltsman, A. B., George, S. J. & Newby, A. C. (1998). Divergent effects of tissue inhibitor of metalloproteinase-1, -2 or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest 101: 1478–1487.
Bass, K. E., Li, H. X., Hawkes, S. P., Howard, E., Bullen, E., Vu, T. K. H., McMaster, M., Janatpour, M. & Fisher, S. J. (1997). Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Dev Genet 21: 61–67.
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J. A. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197–250.
Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S. & Tschesche, H. (1994). The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 13: 1263–1269.
Byrne, J. A., Tomasetto, C., Rouyer, N., Bellocq, J. P., Rio, M. C. & Basset, P. (1995). The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: identification of multiple polyadenylation sites and a stromal pattern of expression. Mol Med 1: 418–427.
DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E. & Taylor, S. M. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708.
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G. & Reynolds, J. J. (1985). Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66–69.
Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S. T. & Clowes, A. W. (1996). Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 79: 812–820.
George, S. J., Johnson, J. L., Angelini, G. D., Newby, A. C. & Baker, A. H. (1998). Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits SMC migration and neointima formation in human saphenous vein. Hum Gene Ther 9: 867–877.
Imren, S., Kohn, D. B., Shimada, H., Blavier, L. & DeClerck, Y. A. (1992). Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 56: 2891–2895.
Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F. & Groom, A. C. (1994). Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791–4797.
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P. & Edwards, D. R. (1994). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352–9360.
Leco, K. J., Apte, S. S., Taniguchi, G. T., Hawkes, S. P., Khokha, R., Schultz, G. A. & Edwards, D. R. (1997). Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): CDNA isolation and expression in adult mouse tissues. FEBS Lett 401: 213–217.
Low, J. A., Johnson, M. D., Bone, E. A. & Dickson, R. B. (1996). The matrix metalloproteinase inhibitor Batimastat (BB-94) retards human breast cancer solid tumor-growth but not ascites formation in nude mice. Clin Cancer Res 2: 1207–1214.
Montgomery, A. M. P., Mueller, B. M., Reisfeld, R. A., Taylor, S. M. & Declerck, Y. A. (1994). Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473.
Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. & Docherty, A. J. P. (1992). The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283: 637–641.
Noel, A. C., Calle, A., Emonard, H. P., Nusgens, B. V., Simar, L., Foidart, J., Lapiere, C. M. & Foidart, J. M. (1991). Invasion of reconstituted basement-membrane matrix is not correlated to the malignant metastatic cell phenotype. Cancer Res 51: 405–414.
Nuovo, G. J. (1997). In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines. Int J Cancer 71: 1056–1060.
Sledge, G. W., Qulali, M., Goulet, R., Bone, E. A. & Fife, R. (1995). Effect of matrix metalloproteinase inhibitor Batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 87: 1546–1550.
Smith, M. R., Kung, H. F., Durum, S. K., Colburn, N. H. & Sun, Y. (1997). TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells. Cytokine 9: 770–780.
Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T. & Liotta, L. A. (1990). Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265: 13933–13938.
Strongin, A. Y., Collier, I., Bannikov, B. L., Grant, G. A. & Goldberg, G. I. (1995). Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 270: 5331–5338.
Sun, Y., Kim, H., Parker, M., Stelerstevenson, W. G. & Colburn, N. H. (1996). Lack of suppression of tumor-cell phenotype by overexpression of TIMP-3 in mouse Jb6 tumor-cells: identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res 16: 1–7.
UrÃa, J. A., Ferrando, A. A., Velasco, G., Freije, J. M. P. & López-OtÃn, C. (1994). Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 54: 2091–2094.
Wang, X., Fu, X., Brown, P. D., Crimmin, M. J. & Hoffman, R. M. (1994). Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-liek orthotopic model in nude mice. Cancer Res 54: 4726–2728.
Wang, M. S., Liu, Y. L. E., Greene, J., Sheng, S. J., Fuchs, A., Rosen, E. M. & Shi, Y. E. (1997). Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14: 2767–2774.
Watanabe, M., Takahashi, Y., Ohta, T., Mai, M., Sasaki, T. & Seiki, M. (1996). Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase-1 gene in nude mice. Cancer 77: 1676–1680.
Watson, S. A., Morris, T. M., Parsons, S. L., Steele, R. J. C. & Brown, P. D. (1996). Therapeutic effect of the matrix metalloproteinase inhibitor, Batimastat, in a human colorectal cancer ascites model. Br J Cancer 74: 1354–1358.
Wick, M., Burger, C., Brusselbach, S., Lucibello, F. C. & Muller, R. (1994). A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation and senescence. J Biol Chem 269: 18953–18960.
Wilkinson, G. W. G. & Akrigg, A. (1992). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20: 2233–2239.
Yang, T. & Hawkes, S. P. (1992). Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured embryo fibroblasts. Proc Natl Acad Sci USA 89: 10676–10680.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Baker, A., George, S., Zaltsman, A. et al. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 79, 1347–1355 (1999). https://doi.org/10.1038/sj.bjc.6690217
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690217
Keywords
This article is cited by
-
Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma
BMC Neurology (2021)
-
Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties
Clinical & Experimental Metastasis (2020)
-
Functional disparities within the TIMP family in cancer: hints from molecular divergence
Cancer and Metastasis Reviews (2019)
-
Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions
Lung (2016)
-
In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines
In Vitro Cellular & Developmental Biology - Animal (2016)
